{"id":982,"date":"2018-02-09T13:40:23","date_gmt":"2018-02-09T13:40:23","guid":{"rendered":"https:\/\/www.ggkmedia.com\/?p=982"},"modified":"2019-09-28T17:19:13","modified_gmt":"2019-09-28T15:19:13","slug":"double-bond-pharmaceutical-startar-drugsson","status":"publish","type":"post","link":"https:\/\/www.drugsson.com\/sv\/double-bond-pharmaceutical-startar-drugsson\/","title":{"rendered":"Double Bond Pharmaceutical startar Drugsson"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-repeat:repeat;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:90px;--awb-padding-bottom:90px;--awb-background-color:#eaf7ff;--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:30px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h3>Double Bond Pharmaceutical startar Drugsson<\/h3>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:50px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;--awb-border-color:#25afb4;--awb-border-bottom:8px;--awb-border-style:solid;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-2\"><p>Double Bond Pharma (DBP) har idag startat ett nytt dotterbolag, DRUGSSON AB, f\u00f6r distribution av l\u00e4kemedel.<\/p>\n<p>DBP \u00e4ger 100% av Drugsson AB som kommer att bli en distribut\u00f6r f\u00f6r alla l\u00e4kemedelsprodukter in-licenserade av moderbolaget.<\/p>\n<p>&#8220;Syftet med det nyregistrerade bolaget \u00e4r att separera olika verksamheter b\u00e5de id\u00e9m\u00e4ssigt och marknadsf\u00f6ringsm\u00e4ssigt, &#8211; kommenterar VD Igor Lokot, &#8211; Vi planerar att licensera in flera produkter under 2018 och fram\u00e5t f\u00f6r att f\u00e5 int\u00e4kter till moderbolaget f\u00f6r att kunna bedriva v\u00e5r huvudverksamhet &#8211; utveckling av v\u00e5ra egna l\u00e4kemedel.&#8221;<\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-3\"><h4>Nyhetsk\u00e4lla<\/h4>\n<\/div><div class=\"fusion-text fusion-text-4\"><p><a href=\"https:\/\/www.spotlightstockmarket.com\/sv\/market-overview\/nyheter\/nyhets-artikel\/?id=42881&amp;publisher=370\" target=\"_blank\" rel=\"noopener noreferrer\">Spotlight<\/a><\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-sharing-box fusion-sharing-box-1 boxed-icons has-taglines layout-floated layout-medium-floated layout-small-floated\" style=\"background-color:#f6f6f6;--awb-layout:row;--awb-alignment-small:space-between;\" data-title=\"Double Bond Pharmaceutical startar Drugsson\" data-description=\"Double Bond Pharmaceutical startar Drugsson    Double Bond Pharma (DBP) har idag startat ett nytt dotterbolag, DRUGSSON AB, f\u00f6r distribution av l\u00e4kemedel.DBP \u00e4ger 100% av Drugsson AB som kommer att bli en distribut\u00f6r f\u00f6r alla l\u00e4kemedelsprodukter in-licenserade av moderbolaget.&quot;Syftet med det nyregistrerade bolaget \u00e4r att separera olika verksamheter b\u00e5de\" data-link=\"https:\/\/www.drugsson.com\/sv\/double-bond-pharmaceutical-startar-drugsson\/\"><h4 class=\"tagline\" style=\"color:#4c5166;\">Dela inl\u00e4gget<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1 boxed-icons\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharmaceutical-startar-drugsson%2F&amp;t=Double%20Bond%20Pharmaceutical%20startar%20Drugsson\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#ffffff;background-color:#3b5998;border-color:#3b5998;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/x.com\/intent\/post?text=Double%20Bond%20Pharmaceutical%20startar%20Drugsson&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharmaceutical-startar-drugsson%2F\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"X\" aria-label=\"X\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"X\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#ffffff;background-color:#000000;border-color:#000000;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fdouble-bond-pharmaceutical-startar-drugsson%2F&amp;title=Double%20Bond%20Pharmaceutical%20startar%20Drugsson&amp;summary=Double%20Bond%20Pharmaceutical%20startar%20Drugsson%20%20%20%20%20%20%20%0D%0A%0D%0ADouble%20Bond%20Pharma%20%28DBP%29%20har%20idag%20startat%20ett%20nytt%20dotterbolag%2C%20DRUGSSON%20AB%2C%20f%C3%B6r%20distribution%20av%20l%C3%A4kemedel.%0D%0A%0D%0ADBP%20%C3%A4ger%20100%25%20av%20Drugsson%20AB%20som%20kommer%20att%20bli%20en%20distribut%C3%B6r%20f%C3%B6r%20alla%20l%C3%A4kemedelsprodukter%20in-licenserade%20av%20moderbolaget.%0D%0A%0D%0A%26quot%3BSyftet%20med%20det%20nyregistrerade%20bolaget%20%C3%A4r%20att%20separera%20olika%20verksamheter%20b%C3%A5de\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#ffffff;background-color:#0077b5;border-color:#0077b5;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/982"}],"collection":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/comments?post=982"}],"version-history":[{"count":4,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/982\/revisions"}],"predecessor-version":[{"id":1389,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/982\/revisions\/1389"}],"wp:attachment":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/media?parent=982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/categories?post=982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/tags?post=982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}